1/33
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Celexa → generic
Lexapro → generic
MOA →
ADE →
DDI →
Unique
Highest rates of…(ADE)
Max doses…(if >60 yo…)
Celexa → Citalopram
Lexapro → Escitalopram
MOA → SSRIs increase 5-HT
ADE → sexual dysfunction, bleeding
DDI →
MAOIs and other serotonergic agents
Bleeding agents (anticoag, antiplatelets, NSAIDs, ginkgo, garlic, ginger, ginseng, glucosamine, fish oil)
Unique
Highest rates of QTc prolongation
Good in pregnancy (just like Sertraline)
Max doses
Citalopram: 40 mg/day (if >60 yo → 20 mg/day)
Escitalopram: 20 mg/day (if >60 yo → 10 mg/day)
Citalopram (Celexa), Escitalopram (Lexapro), Fluoxetine (Prozac), Paroxetine (Paxil), Sertraline (Zoloft), Fluvoxamine (Luvox)
Prozac → generic
Paxil → generic
MOA →
ADE → (2)
DDI →
(2)
Unique →
CYP…
Most…, t1/2
Prozac → Fluoxetine
Paxil → Paroxetine
MOA → SSRIs increase 5-HT
ADE → sexual dysfunction, bleeding
DDI →
MAOIs and other serotonergic agents
Bleeding agents (anticoag, antiplatelets, NSAIDs, ginkgo, garlic, ginger, ginseng, glucosamine, fish oil)
Unique →
Both CYP2D6 inhibitor (decrease tamoxifen efficacy)
Fluoxetine → Most activating, longest t1/2
Paroxetine → Most sedating, shortest t1/2
Citalopram (Celexa), Escitalopram (Lexapro), Fluoxetine (Prozac), Paroxetine (Paxil), Sertraline (Zoloft), Fluvoxamine (Luvox)
Zoloft
Generic
MOA →
ADE →
DDI →
(2)
Unique →
Good for…(population)
Sertraline
MOA → SSRIs increase 5-HT
ADE → sexual dysfunction, bleeding
DDI →
MAOIs and other serotonergic agents
Bleeding agents (anticoag, antiplatelets, NSAIDs, ginkgo, garlic, ginger, ginseng, glucosamine, fish oil)
Unique →
Good in pregnancy (just like Citalopram)
Citalopram (Celexa), Escitalopram (Lexapro), Fluoxetine (Prozac), Paroxetine (Paxil), Sertraline (Zoloft), Fluvoxamine (Luvox)
Luvox
Generic
MOA →
Indication →
Fluvoxamine
MOA → SSRI
Indication → only OCD (not the usual depression)
Citalopram (Celexa), Escitalopram (Lexapro), Fluoxetine (Prozac), Paroxetine (Paxil), Sertraline (Zoloft), Fluvoxamine (Luvox)
Viibryd → generic, Regards to food
Trintellix → generic, CYP
Nefazodone → ADE
Trazodone → ADE, off label indication
MOA →
Less…(ADE)
Viibryd → Vilazodone, Take with food
Trintellix → Vortioxetine, CYP2D6 substrate (avoid with CYP2D6 inhibitors like fluoxetine and paroxetine)
Nefazodone → hepatotoxicity
Trazodone → priapism, off label indication sleep (50-100 mg QHS)
-
MOA → serotonin modulator
Less sexual dysfunction
Effexor XR → generic
Cymbalta → generic
Pristiq → generic
MOA →
ADE →
DDI →
Effexor XR → Venlafaxine
Cymbalta → Duloxetine
Pristiq → Desvenlafaxine
MOA → SNRI (both serotonin and NEP)
ADE → increase HR, dilated pupils, constipation, excessive sweating esp in Venlafaxine
think NEP = stimulating
DDI → MAOI and other serotonergic agents
Amitriptyline
Doxepin
Pamelor → generic
Which are tertiary vs secondary amines
Indication →
Amitriptyline →
Silenor →
MOA →
ADE →
MOA → ADE (2)
DDI → (1)
Silenor → generic, indication
Tertiary amines
Amitriptyline
Doxepin
Secondary amines
Pamelor → Nortriptyline
Indication → depression (not as much anymore)
Amitriptyline → migraine ppx
Silenor → Doexpin used for insomnia
MOA → block serotonin and NE reuptake (just like SNRI)
ADE →
Anticholinergic → dry mouth, blurred vision, urinary retention, constipation
Antihistamine → sedation, weight gain
DDI → MAOIs
Generic
Wellbutrin XL → indication
Zyban → indication
Auelity → generic, formulation, indication
Contrave → generic, indication
-
MOA →
CI in…(2 conditions)
DDI →
Bupropion
Wellbutrin XL → depression, seasonal affective disorder
Zyban → smoking cessation
Auelity → Dextromethorphan + Bupropion, ER tabs, depression
Contrave → Bupropion + Naltrexone, weight management
-
MOA → DNRI (dopamine and NEP reuptake inhibitor, just like mini stimulants)
No sexual dysfunction (Doesnt touch serotonin)
CI in seizure disorder, anorexia/bulimia (seizure risk)
DDI → MAOIs
Marplan → generic
Nardil → generic
Parnate → generic
Emsam → generic (formulation, frequency)
MOA, ADE
Marplan → Isocarboxazid
Nardil → Phenelzine
Parnate → Tranylcypromine
Emsam → Selegiline (patch QD, MAO-B inhibitor at low doses)
MAOIs that can cause serotonin syndrome


Remeron
ADE→ (2)
Indication → (2)
Mirtazapine
ADE → sedation and weight gain
Indication → often used for sleep and increase appetite
Antipsychotics approved for MDD
Antipsychotics approved for Bipolar disorder
Antipsychotics approved for MDD
Aripiprazole (Abilify)
Brexpiprazole (Rexulti)
Quetiapine (Seroquel)
Olanzapine/Fluoxetine (Symbyax)
Antipsychotics approved for Bipolar disorder
Aripiprazole
Quetiapine
Olanzapine
Asenapine
Risperidone
Ziprasidone
Lurasidone
Symbyax
Generic
Indication →
Taken at…(time of day)
Olanzapine/Fluoxetine
MOA → adjunctive therapy for treatment resistant depression
Taken at night (fluoxetine activating but olanzapine sedating)
Spravato
MOA →
Formulation →
Schedule…controlled substance, only given by…
Must check…
Esketamine
MOA → NMDA receptor antagonist
Formulation → nasal spray
Schedule 3 controlled substance, only given by healthcare provider
Must check BP
Depression Diagnosis
OTC meds for depression

OTC meds for depression:
St John’s Worts
SAMe also for osteoarthritis
DSM-5 Diagnostic Criteria for Schiz
Negative vs Pos s/s


EPS Side Effects
More common in…
Test →
Akathisia (presentation) → DOC
Dystonia (presentation) → DOC
Pseudoparkinsonism → DOC
More common in first gen antipsychotics
Test → AIMS (abnormal involuntary movement scale)
Akathisia (inner restlessness) → propranolol (alt → BZD)
Dystonia (involuntary muscle contractions) → Bentropine
Pseudoparkinsonism → anticholinergics (Trihexyphenidyl, Diphenhydramine, Benztropine, Amantadine)
TD (lip smacking, involuntary tongue movementsm, side jaw movements) →
Antipsychotics (both typical and atypical)
MOA:
First gen (typical) antipsychotic →
Second gen (atypical) antipsychotic →
ADE
(6)
MOA:
First gen (typical) antipsychotic → block D2 receptors (affect pos symptoms)
Second gen (atypical) antipsychotic → block D2 AND 5-HT2 receptors (affect pos AND neg symptoms)
ADE
Sedation
EPS
TD (use lowest dose or switch to clozapine)
Hyperprolactinemia → release milk (only fluid high secretion bc anticholinergic)
Anticholinergic ADE (mainly clozapine)
Neuro malignant syndrome (central autonomic instability → muscle rigidity, hyperthermia, CK >1000) tx →
Stop antipsychotic. Control patient temp.
Relax muscles → Dantrolene and sometimes Bromocriptine (increase DA)
Try new antipsychotic once better
Chlorpromazine → …potency → ADE
Generic → …potency → ADE
Haldol → formulation
Haloperidol Decanoate → formulation, frequency
Fluphenazine decanoate → …potency, formulation, frequency
Chlorpromazine → low potency → high sedation, low EPS
Haloperidol → high potency → low sedation, high EPS
Haldol → PO, IV/IM
Decanoate → IM only, monthly
Fluphenazine decanoate → high potency, IM, Q 2 weeks

Antipsychotics formulations
Oral solution → acronym
Names
ODT → acronym
Names
Rapid acting IM → acronym
Names
Use if patient has QTc prolongation → acronym
Names
Oral solution → H-CAR
Haloperidol
Clozapine
Aripiprazole
Risperidone
ODT → O-CAR
Olanzapine
Clozapine
Aripiprazole
Risperidone
Rapid acting IM → HZZ
Haloperidol
Ziprasidone
Zyprexa
Use if patient has QTc prolongation → C LAB
Cariprazine
Lurasidone
Aripiprazole
Brexpiprazole
Antipsychotics formulations
Long acting injectables → acronym
Names
Long acting injectables → OPAR-HF
Olanzapine
Zyprexa Relprevv → Q2-4 weeks
Paliperidone
Invega Sustenna → Q monthly, no overlap
Invega Trinza, Invega Hafyera → Q3 months, Q6 months respectively, both overlap with Sustenna for at least 4 weeks
Aripiprazole
Abilify Maintena or Abilify Asimtufii → Q monthly, Q2 months respectively, both 2 weeks overlap
Aristada → Q1-2 months, 3 weeks overlap
Risperidone (SQ)
Risperidone Consta, Rykindo → Q2 weeks, Consta overlap for 3 weeks
Perseris → Q monthly
Uzedy → Q1-2 months
Haloperidol
Haloperidol decanoate → Q monthly
Fluphenazine
Fluphenazine decanoate → Q 2 weeks

Generic, class
Abilify Maintena → LAI frequency
Aristada → LAI frequency
Abilify Asimtufil → LAI frequency
Rexulti → generic
ADE → (1)
-
Formulation
QTc
Aripiprazole, 2nd gen antipsychotic (D2 partial agonist, not the usual antagonism)
Abilify Maintena → Q monthly
Aristada → Q 1-2 months
Abilify Asimtufil → Q 2 months
Rexulti → Brexpiprazole
ADE → Akathsia (-piprazole)
-
Oral solution → H-CAR
Haloperidol
Clozapine
Aripiprazole
Risperidone
ODT → O-CAR
Olanzapine
Clozapine
Aripiprazole
Risperidone
Use if patient has QTc prolongation → C LAB
Cariprazine
Lurasidone
Aripiprazole
Brexpiprazole
-
Paliperidone
Invega Trinza, Invega Hafyera → Q3 months, Q6 months respectively, both overlap with Sustenna for at least 4 weeks
Aripiprazole
Abilify Maintena or Abilify Asimtufii → Q monthly, Q2 months respectively, both 2 weeks overlap
Risperidone
Risperidone Consta, Rykindo → Q2 weeks, Consta ONLY overlap for 3 weeks

Clozaril
Indication →
ADE →
Unique
Does NOT cause…
ADE (discontinued REMS)
Before starting, ANC…
Stop when ANC…
-
Formulation
Clozaril
Clozapine, 2nd gen antipsychotic
Indication → treatment resistant schiz
ADE → metabolic syndrome, weight gain (-apine)
Unique
Does NOT cause EPS or TD (good to switch if have TD from other meds)
Agranulocytosis (discontinued REMS)
Before starting, ANC >1,500/mm3
Stop when ANC <1000/mm3
-
Oral solution → H-CAR
Haloperidol
Clozapine
Aripiprazole
Risperidone
ODT → O-CAR
Olanzapine
Clozapine
Aripiprazole
Risperidone
Lutada → formulation, regards to food
Geodon → formulation, regards to food, ADE
Seroquel → formulation, regards to food
2nd gen antipyschotic
Lutada → Lurasidone, with food
Geodon → Ziprasidone, with food, QTc prolongation
Seroquel → Quetiapine, empty stomach
-
ADE →
-done → EPS
-apine → weight gain, metabolic syndrome
-
Use if patient has QTc prolongation → C LAB
Cariprazine
Lurasidone
Aripiprazole
Brexpiprazole
Generic
Zyprexa
Zydis → formulation
Zyprexa Relprevv → formulation, frequency,…program
ADE →
Formulation
Symbyx → generic
Lybalvi → generic
Olanzapine
Zyprexa
Zydis → ODT
Zyprexa Relprevv → LAI IM, Q 2-4 weeks, REMS program (monitored for 3 hrs post injection)
ADE → metabolic syndrome, weight gain (-apine)
Symbyx → Olanzapine + Fluoxetine
Lybalvi → Olanzapine + Samidorphan (decrease Olanzapine-induced weight gain
-
ODT → O-CAR
Olanzapine
Clozapine
Aripiprazole
Risperidone

Generic
Invega Sustenna →
Invega Trinza, Invega Hafyera →
ADE →
Paliperidone
Invega Sustenna → IM Q monthly, no overlap
Invega Trinza, Invega Hafyera → IM Q3 months, Q6 months respectively, both overlap with Sustenna for at least 4 weeks)
ADE → EPS (-done)
-
Paliperidone
Invega Trinza, Invega Hafyera → Q3 months, Q6 months respectively, both overlap with Sustenna for at least 4 weeks
Aripiprazole
Abilify Maintena or Abilify Asimtufii → Q monthly, Q2 months respectively, both 2 weeks overlap
Risperidone
Risperidone Consta, Rykindo → Q2 weeks, Consta ONLY overlap for 3 weeks

Generic, class
Risperidone Consta, Rykindo → formulation, frequency
Perseris → formulation, frequency
Uzedy → formulation, frequency
ADE →
Risperidone, 2nd gen antipsychotics
Risperidone Consta, Rykindo → IM, Q2 weeks (Consta overlap for 3 weeks)
Perseris → SQ, Q monthly
Uzedy → SQ, Q1-2 months
All other 2nd gens are IM
ADE → EPS (-done)
-
Oral solution → H-CAR
Haloperidol
Clozapine
Aripiprazole
Risperidone
ODT → O-CAR
Olanzapine
Clozapine
Aripiprazole
Risperidone
-
Paliperidone
Invega Trinza, Invega Hafyera → Q3 months, Q6 months respectively, both overlap with Sustenna for at least 4 weeks
Aripiprazole
Abilify Maintena or Abilify Asimtufii → Q monthly, Q2 months respectively, both 2 weeks overlap
Risperidone
Risperidone Consta, Rykindo → Q2 weeks, Consta ONLY overlap for 3 weeks

Generic
Saphris → formulation
Secuado → formulation
ADE →
Asenapine, 2nd gen antipsychotic for bipolar
Saphris → SL, dont eat/drink for 10 min
Secuado → patch
ADE→ tongue numbness (for SL)
Mania Diagnosis
Bipolar 1 vs 2

Bipolar 1 (mania + depression) vs Bipolar 2 (HYPOmania + depression)

Lithobid
Generic
Levels →
Clearance rule →
DDI
Increase Lithium levels
Decrease Lithium
Increase risk of…
Manageable ADE
(5)
Toxicity signs
Lithium carbonate vs citrate (formulation, %)
Equivalence
Avoid in…(population)
Lithium
Levels → 0.6-1.2 mEq/L (trough)
Clearance rule → Low sodium = high lithium (and vice versa)
DDI
Increase Lithium levels
NSAIDs (except Aspirin, Sulindac), ACEi/ARBs → high K → low Na
thaizide/loops → low Na
Renal insufficiency, dehydration, Na restrictions
Decrease Lithium
Caffeine, Theophylline
High salt intake, sodium bicarb
Acetazolamide
Pregnancy
Increase risk of serotonin syndrome with SSRI/triptans
Manageable ADE
Hand tremor (treat with propranolol)
Hyper/Hypothyroidism
Hypercalcemia / Hyperparathyroidism
Weight gain and GI upset (take with food)
Polyuria, polydipsia
Toxicity signs
Mild-Moderate: Coarse hand tremor, persistent diarrhea, vomiting, hyperreflexia, slurred speech.
Severe (> 2.0 mEq/L): CNS depression, arrhythmias, seizures, coma, death.
Lithium carbonate caps/ tabs (40%)
Lithium citrate syrup (20%)
300 mg of Lithium Carbonate = 8 mEq = 5 mL of Lithium Citrate syrup
Avoid in pregnancy
Meds also indicated for bipolar disorder
Antiseizure meds (3)
2nd gen antipsychotics (6)
Antiseizure meds
Lamotrigine
Valproate (and deriv)
Carbamazepine
2nd gen antipsychotics → LOZ-QAR
Lurasidone
Olanzapine
Ziprasidone
Quetiapine
Aripiprazole
Risperidone
Anti-anxiety meds
First line →
Beta blocker →
Alt →
First line → SSRI, SNRI
Beta blocker → Propranolol (stage fright)
Alt → BZD
Buspar
Generic
MOA → ADE
Indication →
Buspirone
MOA → unknown, effect on serotonin receptors → serotonin syndrome (avoid MAOIs, 14 days)
Indication → anxiety without tolerance/dependence issues (vs BZD)
Takes 4 weeks to work
Class
Xanax → generic
Klonopin → generic
Valium → generic
Ativan → generic
MOA →
Indication
(3)
Schedule…controlled substance (abuse, dependence, tolerance w chronic use)
ADE
Avoid in…(2 populations, 1 condition)
If used in elderly and hepatic impairment →
t1/2
Short → (1)
Intermediate → (1)
Long → (2)
BZD
Xanax → Alprazolam
Klonopin → Clonazepam
Valium → Diazepam
Ativan → Lorazepam
MOA → enhance GABA (just like Phenobarbital, Primidone, Propofol, Ethanol) → think CNS/resp depression
Indication
Anxiety after SSRI/SNRIs
Sleep after non-BZD hypnotics (ie Zolpidem)
Seizures
IV/IM → Lorazepam, Diazepam (Valium), Midazolam
Rectal → Diazepam (Diastat)
Schedule 5 controlled substance (abuse, dependence, tolerance w chronic use)
ADE: Confusion, amnesia, abuse
Avoid in pregnancy and age >65 yo, liver disease
If used in elderly and hepatic impairment → LOT drugs (metabolized via conjugation and cleared by kidneys)
Lorazepam
Oxazepam
Temazepam
t1/2
Short → Lorazepam
Intermediate → Alprazolam
Long → Diazepam, Clonazepam
2nd gen antipsychotics
Highest rates of weight gain → 2
Highest rates of EPS → 2
Lowest rates of EPS → 2
Highest rates of weight gain → Clozapine, Olanzapine
Highest rates of EPS → Risperidone, Paliperidone
Lowest rates of EPS → Clozapine, Quetiapine